Clinical Trials Browser

Completed × Central Nervous System Neoplasms × pevonedistat × Clear all

NCT03323034 2024-10-22

Pevonedistat, Irinotecan, and Temozolomide in Treating Patients With Recurrent or Refractory Solid Tumors or Lymphoma

Phase 1 Completed

30 enrolled 19 charts

Lymphoma, Central Nervous System Neoplasms